Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EYA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PWWP2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNHIT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NPHP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARRDC3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MPZL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOPC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EFNA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLXND1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928521 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGRN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC645188 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHYHIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UTP23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNJ5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on